Sophie Miriam Lanzkron, M.D., M.H.S.

Headshot of Sophie Miriam Lanzkron
  • Director, Sickle Cell Center for Adults, The Johns Hopkins Hospital
  • Professor of Medicine
Female

Expertise

Hematology, Sickle Cell Disease

Research Interests

sickle cell disease

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-955-3142
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287
The Johns Hopkins Hospital (Main Entrance) - Google Maps

Background

Dr. Sophie Lanzkron is a professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hematology and sickle cell disease. Dr. Lanzkron is director of the Sickle Cell Center for Adults at Johns Hopkins.

Dr. Lanzkron received her undergraduate degree in biology from Brandeis University. She earned her M.D. from Albert Einstein College of Medicine. She completed her residency at the University of Maryland Medical Center and performed her fellowship in hematology at Johns Hopkins. She joined the faculty of Johns Hopkins in 2000.

Her research focuses on sickle cell disease.

...read more

Titles

  • Director, Sickle Cell Center for Adults, The Johns Hopkins Hospital
  • Professor of Medicine
  • Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Albert Einstein College of Medicine (1991)

Residencies

  • General Internal Medicine; University of Maryland Medical Center (1994)

Fellowships

  • Hematology; Johns Hopkins University School of Medicine (1997)

Board Certifications

  • American Board of Internal Medicine (Hematology) (1996)

Research & Publications

Research Summary

Dr. Lanzkron's major clinical research involves the study of sickle cell disease. Her primary research interest is to understand the barriers to care for adults with sickle cell disease. She has done pivotal work on barriers to the use of hydroxyurea to treat people with sickle cell disease. Her research has also focused on the benefits of the use of infusion clinics for the management of uncomplicated painful episodes culminating in a multisite study demonstrating improved patient centered outcomes when comparing infusion clinics to  emergency departments in managing such episodes.  Research is ongoing to implement the infusion clinic model across the US.

Clinical Trial Keywords

sickle

Activities & Honors

Honors

  • Unsung Hero Award, William E. Proudford Sickle Cell Fund, 2007
  • Dr. Susan M. MacDonald Sponsorship Award for Excellence in Sponsoring the Advancement of Women Faculty, 2021
Is this you? Edit Profile
back to top button